Clearmind Medicine Inc

XCNQ:CMND (Canada)   Ordinary Shares
C$ 1.60 (-12.57%) Mar 14
At Loss
P/B:
0.99
Market Cap:
C$ 5.07M ($ 3.74M)
Enterprise V:
C$ -304.00K ($ -224.00K)
Volume:
-
Avg Vol (2M):
3.16K
Also Trade In:
Volume:
-
At Loss
Avg Vol (2M):
3.16K

Business Description

Clearmind Medicine Inc
NAICS : 541714 SIC : 3741
ISIN : CA23258C1041

Share Class Description:

XCNQ:CMND: Ordinary Shares
Description
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.
Name Current Vs Industry Vs History
Cash-To-Debt 1102.8
Equity-to-Asset 0.17
Debt-to-Equity 0.01
Interest Coverage No Debt
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 22.7
9-Day RSI 31.12
14-Day RSI 37
6-1 Month Momentum % -74.53
12-1 Month Momentum % -98.8

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.17
Quick Ratio 1.17
Cash Ratio 1.11

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -205.2
Shareholder Yield % -218.65
Name Current Vs Industry Vs History
ROE % -410.19
ROA % -195.51
ROIC % -383.06
ROC (Joel Greenblatt) % -31270.27
ROCE % -310.24

Financials (Next Earnings Date:2024-06-28 Est.)

XCNQ:CMND's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Clearmind Medicine Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil C$)
EPS (TTM) (C$) -57.701
Beta 2.74
Volatility % 93.82
14-Day RSI 37
14-Day ATR (C$) 0.194463
20-Day SMA (C$) 2.0615
12-1 Month Momentum % -98.8
52-Week Range (C$) 1.25 - 165.3
Shares Outstanding (Mil) 3.17

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Clearmind Medicine Inc Filings

Filing Date Document Date Form
No Filing Data

Clearmind Medicine Inc Stock Events

Financials Calendars
Event Date Price(C$)
No Event Data

Clearmind Medicine Inc Frequently Asked Questions

What is Clearmind Medicine Inc(XCNQ:CMND)'s stock price today?
The current price of XCNQ:CMND is C$1.60. The 52 week high of XCNQ:CMND is C$165.30 and 52 week low is C$1.25.
When is next earnings date of Clearmind Medicine Inc(XCNQ:CMND)?
The next earnings date of Clearmind Medicine Inc(XCNQ:CMND) is 2024-06-28 Est..
Does Clearmind Medicine Inc(XCNQ:CMND) pay dividends? If so, how much?
Clearmind Medicine Inc(XCNQ:CMND) does not pay dividend.

Press Release

Subject Date
No Press Release